Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.


-0.0244 (-3.12%)
Jun 15 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
HOOKIPA Pharma Inc HOOK NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0244 -3.12% 0.7576 00:00:07
Open Price Low Price High Price Close Price Prev Close
0.77 0.72 0.7877 0.7435 0.782
more quote information »

Recent News

Date Time Source Heading
6/04/202416:15EDGAR2Form 8-K - Current report
6/04/202413:00GLOBEHOOKIPA Pharma Announces Updated Phase 2 Clinical Data at..
5/30/202416:30GLOBEHOOKIPA Pharma to Host Investor Call on HB-200 Data..
5/23/202417:05EDGAR2Form 8-K - Current report
5/23/202417:01GLOBEHOOKIPA Pharma Announces Positive Clinical Data to be..
5/09/202407:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/09/202407:03EDGAR2Form 8-K - Current report
5/09/202407:01GLOBEHOOKIPA Pharma Reports First Quarter 2024 Financial..
4/25/202407:01GLOBEHOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for..
4/24/202407:01GLOBEHOOKIPA Pharma Announces FDA Clearance of its..
4/16/202416:30GLOBEHOOKIPA Pharma Announces Grant of Inducement Award Under..
4/10/202407:01GLOBEHOOKIPA Pharma to Host Investor Call on HB-200 and Planned..
3/22/202407:01GLOBEHOOKIPA Pharma Reports Fourth Quarter and Full Year 2023..
3/06/202407:01GLOBEHOOKIPA Pharma to Participate in Leerink Partners Global..
1/31/202416:30EDGAR2Form 8-K - Current report
1/29/202408:12EDGAR2Form 8-K - Current report
1/29/202408:01GLOBEHOOKIPA Pharma Provides Update on Business Priorities and..
1/16/202407:01GLOBEHOOKIPA Pharma Appoints Mark Winderlich as Chief Development..
1/05/202400:15EDGAR2Form EFFECT - Notice of Effectiveness
12/22/202307:33EDGAR2Form S-3 - Registration statement under Securities Act of..
12/21/202307:06EDGAR2Form 8-K - Current report
12/21/202307:01GLOBEHOOKIPA Pharma Announces $21.25 Million Equity Investment..
12/01/202316:46EDGAR2Form 8-K - Current report
11/20/202307:01GLOBEHOOKIPA Pharma Announces FDA Clearance of its..
11/09/202307:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/202307:05EDGAR2Form 8-K - Current report
11/09/202307:01GLOBEHOOKIPA Pharma Reports Third Quarter 2023 Financial..
11/03/202312:01GLOBEHOOKIPA Pharma Presents Positive Biomarker and Translational..
11/02/202316:01GLOBEHOOKIPA Pharma to Report Third Quarter 2023 Financial..
10/22/202306:01GLOBEHOOKIPA Pharma Presents Additional Preliminary Phase 2 Data..
10/20/202316:05EDGAR2Form 8-K - Current report
10/18/202307:01GLOBEHOOKIPA Pharma announces publication of preclinical data of..
9/13/202308:47EDGAR2Form 8-K - Current report
9/13/202308:45GLOBEHOOKIPA Announces Executive Leadership Change
9/12/202308:01EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
9/12/202307:01GLOBEHOOKIPA Announces Grant of Inducement Awards Under Nasdaq..
9/06/202307:01GLOBEHOOKIPA Pharma to participate in upcoming investor..
8/22/202316:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/17/202316:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/10/202316:13EDGAR2Form SC TO-I - Tender offer statement by Issuer
8/10/202307:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/202307:05EDGAR2Form 8-K - Current report
8/10/202307:01GLOBEHOOKIPA Pharma Reports Second Quarter 2023 Financial Results..
8/04/202316:10EDGAR2Form 8-K - Current report
8/03/202307:01GLOBEHOOKIPA Pharma to Report Second Quarter 2023 Financial..
7/03/202316:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Your Recent History

Delayed Upgrade Clock